Thierry Gustot, Rajiv Jalan  Journal of Hepatology 

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 61, Issue 2, Pages (August 2014)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
MELD: the holy grail of organ allocation?
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Tiny RNA with great effects: miR-155 in alcoholic liver disease
Reply to: “Serum HBV pgRNA as a clinical marker for cccDNA activity”
Volume 42, Issue 6, Pages (June 2005)
Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou 
Volume 61, Issue 6, Pages (December 2014)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Immigration and viral hepatitis
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute- on-chronic liver failure  Manuel Romero-Gómez, Sara Montagnese, Rajiv.
Volume 66, Issue 1, Pages 1-4 (January 2017)
Living donor liver transplantation: is the hype over?
Mesenchymal stromal cell therapy for liver diseases
Reply to: “DCD consensus and futility in liver transplantation”
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure”  Rakhi Maiwall,
European Association for the Study of the Liver  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Volume 70, Issue 1, Pages (January 2019)
Acute-on chronic liver failure
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Aloysious D. Aravinthan, Graeme J.M. Alexander  Journal of Hepatology 
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Autophagy in the liver Journal of Hepatology
Volume 59, Issue 3, Pages (September 2013)
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
The changing role of beta-blocker therapy in patients with cirrhosis
Volume 57, Issue 5, Pages (November 2012)
Volume 50, Issue 4, Pages (April 2009)
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Immigration and viral hepatitis
The potential of induced pluripotent stem cell derived hepatocytes
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
Volume 17, Issue 2, Pages (February 1950)
The impact of intestinal microflora on serum bilirubin levels
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
The use of hemospray in portal hypertensive bleeding; a case series
Volume 62, Issue 3, Pages (March 2015)
Liver transplantation in children
Reply to: “Flow cytometry makes all the difference”
Pathogenesis of cholestatic hepatitis C
Inflammatory pathways in alcoholic steatohepatitis
Chimeric mouse model of hepatitis B virus infection
Volume 60, Issue 6, Pages (June 2014)
Genetics of hepatocellular carcinoma: The next generation
MELD: the holy grail of organ allocation?
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Acute-on-chronic liver failure in patients with alcohol-related liver disease  Thierry Gustot, Rajiv Jalan  Journal of Hepatology  Volume 70, Issue 2, Pages 319-327 (February 2019) DOI: 10.1016/j.jhep.2018.12.008 Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Overview of the current hypothesis concerning the pathophysiology of acute-on-chronic liver failure in the context of alcohol-related liver disease. ALD-ACLF, alcohol-related acute-on-chronic liver failure. Journal of Hepatology 2019 70, 319-327DOI: (10.1016/j.jhep.2018.12.008) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Description of pathways and immunogenicity associated with 3 types of cell death (apoptosis, necroptosis and pyroptosis). Journal of Hepatology 2019 70, 319-327DOI: (10.1016/j.jhep.2018.12.008) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.